
Recently we had the opportunity to speak with long time client Api Rudich, Serial Entrepreneur and CEO of MediVector, during our 77th Town Hall. SMA helped MediVector win a $230M program for the development of emerging infectious disease medical countermeasures. MediVector also partnered with SMA to implement a fully validated earned value management system and program management methodology tailored to new drug development.
In this video, Api shares an insider’s view on the pharmaceutical industry and how MediVector’s partnership with SMA paved the way to effective management of large-scale drug development. He also discusses societal values of medicine, economics of the industry and his own personal journey.
